Company on track to produce finished cannabis products such as edibles, cosmetics, topicals, human and veterinary natural health products.
Vancouver, B.C. – March 1, 2018: Will Rascan, President and CEO of Liberty Leaf Holdings Ltd.(CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) (“Liberty Leaf” or “the Company”), announced today the signing of an agreement between North Road Ventures, a wholly-owned subsidiary of the Company, and Cannabis Compliance Inc. (“CCI”). Under the terms of the agreement, CCI will be responsible for shepherding the Good Manufacturing Practice (GMP)-compliant processing/production of North Road’s cannabis-containing and other finished products.
Liberty Leaf is a Canadian-based public company whose objective is to be at the forefront of the cannabis industry, accelerating vertically integrated, revenue-generating businesses within this rapidly growing sector.
Canada is the only G7 country to legalize (expected to occur this summer) both medical and recreational cannabis on a national level. To facilitate this, Canada has established the most stringent requirements for commercial production found anywhere. Achieving compliance means following strict protocols regarding security system designs and procedures, quality assurance programs, record keeping, sanitation and standard operating procedures. At the heart of these requirements are GMPs that ensure the manufacture of finished products that are safe and of a consistently high quality for their intended use.
With more than a decade of extensive experience in cannabis compliance matters, CCI is the ideal partner for guiding North Road to successful authorized/licensed GMP manufacture of finished products, especially cannabis and cannabis-containing products.
A GMP Manufacturing Facility Expected to Deliver on Tremendous Promise
“We are extremely excited to be working with CCI in establishing GMP manufacturing capabilities in-house,” said Robert Jackman, Scientific Project Manager/Fulfillment for the Company. “This opens the door for North Road to obtain industry certification and regulatory authorization and/or licensing, as needed. It facilitates the manufacture and sale of a wide range of medicinal-quality products for both human and veterinary use – not just cannabis and cannabis-containing finished products.”
A Unique Distribution Strategy and Expansion into Natural Health Products
North Road Ventures has a distribution strategy that has not been implemented by any other organization in the cannabis industry.
“North Road plans to make available to both pharmacies and licensed retailers our exclusive medicinal-quality cannabis, cannabis-related products and racking jobber service,” Rascan said. “The ability for us to expand on our model by including Natural Health Products (NHPs) for human and veterinary use as well as cosmetics/beauty products, topicals, concentrates, foods/edibles and other high-quality products for distribution holds tremendous growth potential for our company.”
According to Rascan, these new developments represent an extension of North Road’s existing business model. CCI’s efforts in helping the Company acquire new licenses will be complementary to the Company’s current ACMPR license application.
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a Canadian-based public company whose focus is to build and support a diversified portfolio of cannabis sector businesses, including cultivation, processing, value-added CBD/THC pet products and supply chain products within this dynamic and fast-growing sector.
Liberty Leaf’s late-stage ACMPR portfolio consists of a 60% interest in Just Kush and 100% of North Road Ventures.
On behalf of the Board
Will Rascan, President & CEO
Liberty Leaf Holdings Ltd.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The Company disclaims any intention or obligation to revise or update such statements.